This inventor holds 112 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in HIV Detection Technologies (CPC class 435-5). Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 1981-2021. National Inventors Hall of Fame inductee. Nobel Prize laureate.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Plessis-Robinson, FR (1988)
- Le Pleissis Robinson, FR (1992)
- Le Plessis-Robi, FR (1994)
- Le Plessy Robin, FR (1996)
- Le Plessins Robinson, FR (1996)
- Robinson, FR (1989 - 2001)
- Le Plessy Robinson, FR (1991 - 2005)
- Le Plessis-Robinson, FR (1981 - 2013)
- Le Plessis, FR (1999 - 2021)
Company Filing History:
91 out of 898 
10 out of 5,383 
7 out of 1,853 
Years Active: 1981-2021
Areas of Expertise:
Title: Luc Montagnier: Pioneering Virologist Revolutionizing HIV and AIDS Research
Introduction:
Luc Montagnier, a renowned virologist hailing from Le Plessis Robinson, FR, has made groundbreaking contributions to the field of virology, particularly in HIV and AIDS research. With an impressive portfolio of 112 patents, his work has significantly advanced our understanding of these diseases, leading to crucial developments in diagnosis, treatment, and prevention.
Latest Patents:
Among his latest patents is the "Detection of DNA sequences as risk factors for HIV infection," which presents innovative methods for identifying risk factors linked to diseases caused by human immunodeficiency virus (HIV). This patent includes strategies for treating patients with these conditions using antimicrobial approaches, such as combined antiviral and antibacterial treatments or immune system modulation. Additionally, Montagnier's patents cover methods for screening biological products, especially red blood cell preparations, and detecting nucleic acids or microbial agents associated with HIV-infected individuals undergoing antiretroviral therapy.
Career Highlights:
Throughout his illustrious career, Luc Montagnier has made significant strides in virology, with a strong focus on HIV and AIDS. His dedication to scientific research and unwavering commitment to global health have propelled him to the forefront of medical innovation. Montagnier's extensive patent portfolio reflects his ongoing pursuit of novel solutions to combat infectious diseases, particularly those related to HIV.
Collaborations:
Montagnier has collaborated with esteemed professionals in the field, including Marc Alizon and Pierre Sonigo. Together, they have worked on various research projects and initiatives aimed at advancing our knowledge of virology and improving patient outcomes in the realm of HIV and AIDS.
Conclusion:
Luc Montagnier's pioneering work in virology has had a profound impact on the medical community, shaping our understanding of HIV and AIDS. His innovative research, coupled with a passion for global health, has cemented his legacy as a true trailblazer in the field of infectious diseases. Through his patents and collaborations, Montagnier continues to drive progress in diagnosis, treatment, and prevention strategies, leaving an indelible mark on the fight against HIV and AIDS.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile